Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_1
3
75%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting1
unknown1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 13 (75.0%)
N/A1 (25.0%)

Trials by Status

not_yet_recruiting125%
unknown125%
withdrawn125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

NCT07010523
not_yet_recruitingphase_1

MSLN-targeted CAR-T Cells in Solid Tumors.

NCT05783089
withdrawnphase_1

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors

NCT05531708
unknownphase_1

Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.

NCT03545815

Clinical Trials (4)

Showing 4 of 4 trials
NCT07010523Not Applicable

Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Recruiting
NCT05783089Phase 1

MSLN-targeted CAR-T Cells in Solid Tumors.

Not Yet Recruiting
NCT05531708Phase 1

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors

Withdrawn
NCT03545815Phase 1

Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4